Traditional Chinese medicine cinnabar-ginseng pill for treating pediatric epilepsy

A technology of cinnabar and ginseng, which is applied in the direction of drug combination, pharmaceutical formula, medical raw materials derived from molluscs, etc., can solve the problems of unsatisfactory curative effect and achieve the effect of no toxic side effects

Inactive Publication Date: 2014-05-21
马东升
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] There are many kinds of medicaments for the treatment of epilepsy in children at home and abroad, but the cura

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0007] Take 3-5 parts of ginseng, 3-5 parts of cinnabar, and 3-5 parts of clam powder. The medicine is dried and ground into fine powder. Take pig's heart blood as a pill, which is as big as a phoenix tree seed. Take 1.5-2.5 grams per serving, half the amount for children, and take 2-3 times a day. Can be taken continuously.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a traditional Chinese medicine cinnabar-ginseng pill for treating pediatric epilepsy. The traditional Chinese medicine cinnabar-ginseng pill is mainly used for solving the problem that the current drugs for treating pediatric epilepsy are poor in treatment effect and have side effects. The traditional Chinese medicine cinnabar-ginseng pill is prepared through the steps of weighing 3-5 parts of ginseng, 3-5 parts of cinnabar and 3-5 parts of clam powder, baking, co-grinding into fine powder, and pilling in the size of parasol tree seeds with pig heart blood. The usage and dosage are as follows: the pill is orally taken 2-3 times every day by 1.5-2.5g every time, and the dosage for children is halved; the pill can be orally taken continuously. The traditional Chinese medicine cinnabar-ginseng pill has the aims and advantages that the total effective rate for pediatric epilepsy treatment is over 95%, and the cure rate is over 80%. The traditional Chinese medicine cinnabar-ginseng pill is free from toxic and side effects.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine cinnabar ginseng pill for treating epilepsy in children. Background technique [0002] There are many kinds of medicaments for the treatment of epilepsy in children at home and abroad, but the curative effect is not ideal, and the better cure rate is only about 20%, and the highest one does not exceed 40%. Contents of the invention [0003] The purpose of the invention is to develop a traditional Chinese medicine cinnabar ginseng pill with a cure rate of more than 80%. [0004] The purpose of the present invention is to realize in this way and get 3-5 parts of ginseng, 3-5 parts of cinnabar, 3-5 parts of clam powder. [0005] Usage and Dosage: The medicine is roasted and ground into fine powder. Take pig's heart blood as a pill, which is as big as a phoenix tree seed. Take 1.5-2.5 grams per serving, half the amount for children, and take 2-3 tim...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/258A61P25/08A61K35/56A61K33/28A61K35/618
Inventor 马东升
Owner 马东升
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products